First Time Loading...

Roivant Sciences Ltd
NASDAQ:ROIV

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
NASDAQ:ROIV
Watchlist
Price: 11.33 USD 1.34% Market Closed
Updated: May 15, 2024

Cash Flow Statement

Cash Flow Statement
Roivant Sciences Ltd

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Operating Cash Flow
Net Income
(900)
(993)
(1 165)
(1 196)
(924)
(1 177)
(1 267)
(1 346)
(1 116)
(1 090)
(1 105)
4 353
Depreciation & Amortization
0
0
0
0
0
0
8
13
19
25
23
23
Stock-Based Compensation
85
104
502
573
565
618
283
270
218
194
182
0
Other Non-Cash Items
263
327
380
456
217
384
468
501
247
216
237
(5 244)
Cash Interest Paid
0
0
0
0
1
0
0
0
5
0
0
0
Change in Working Capital
85
85
180
104
30
4
(67)
20
6
8
(3)
32
Cash from Operating Activities
(552)
N/A
(582)
-5%
(605)
-4%
(636)
-5%
(678)
-7%
(789)
-16%
(858)
-9%
(812)
+5%
(843)
-4%
(841)
+0%
(848)
-1%
(836)
+1%
Investing Cash Flow
Capital Expenditures
(6)
(8)
(9)
(15)
(17)
(23)
(23)
(17)
(13)
(6)
(3)
(3)
Other Items
(26)
0
320
320
321
0
(143)
(146)
(32)
(31)
77
5 313
Cash from Investing Activities
(32)
N/A
(8)
+74%
311
N/A
305
-2%
303
-1%
298
-2%
(166)
N/A
(164)
+2%
(44)
+73%
(37)
+17%
74
N/A
5 310
+7 105%
Financing Cash Flow
Net Issuance of Common Stock
457
0
97
97
0
0
0
165
383
404
625
710
Net Issuance of Debt
0
15
15
15
15
153
145
138
130
(31)
(31)
(31)
Other
(0)
(5)
301
293
292
286
(20)
(13)
(13)
(8)
(14)
(17)
Cash from Financing Activities
456
N/A
285
-37%
413
+45%
404
-2%
307
-24%
439
+43%
127
-71%
290
+128%
500
+72%
365
-27%
580
+59%
662
+14%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
6
6
5
8
Net Change in Cash
(128)
N/A
(305)
-139%
120
N/A
73
-39%
(68)
N/A
(52)
+23%
(896)
-1 627%
(685)
+24%
(382)
+44%
(507)
-33%
(190)
+63%
5 144
N/A
Free Cash Flow
Free Cash Flow
(558)
N/A
(590)
-6%
(614)
-4%
(652)
-6%
(695)
-7%
(811)
-17%
(881)
-9%
(829)
+6%
(856)
-3%
(847)
+1%
(851)
0%
(839)
+1%

See Also

Discover More